期刊文献+

髓系特异性SOCS3基因敲除小鼠的构建及应用

Construction and application of myeloid-specific SOCS3 gene knockout mice
下载PDF
导出
摘要 目的:通过Cre-loxP基因敲除系统特异性敲除髓系SOCS3基因,构建早期髓系来源抑制细胞(eMDSCs)高浸润荷瘤鼠模型。方法:通过将SOCS3fl/-小鼠与Lyz2-Cre小鼠杂交繁育,获得髓系特异性SOCS3基因敲除小鼠,PCR法鉴定小鼠基因型,Western印迹验证基因敲除效果,流式细胞术检测髓系特异性SOCS3基因敲除小鼠骨髓中eMDSCs比例及其对T细胞的抑制作用,并在该小鼠基础上分别构建乳腺癌、肺癌和黑色素瘤3种eMDSCs高浸润荷瘤鼠模型,流式细胞术检测肿瘤组织中eMDSCs浸润情况。结果:PCR鉴定和Western印迹检测证实髓系特异性SOCS3基因敲除小鼠构建成功,流式细胞术结果表明髓系SOCS3基因敲除小鼠骨髓中eMDSCs比例显著升高(t=17.94,P<0.001),且该群eMDSCs抑制T细胞增殖(t=14.21,P<0.001)、促进T细胞凋亡(t=13.53,P<0.001)。在黑色素瘤、乳腺癌、肺癌3种髓系特异性SOCS3基因敲除荷瘤鼠的肿瘤组织中eMDSCs数量显著增加(t=24.14、24.56、14.93,均P<0.001)。结论:通过髓系特异性SOCS3敲除可成功构建eMDSCs高浸润荷瘤鼠模型。 Objective:To construct mouse models of cancer with high infiltration of eMDSCs through myeloid-specific SOCS3 gene knockout mice based on the Cre-loxP system.Methods:SOCS3fl/fl mice were crossed with Lyz2-Cre mice to generate myeloid-specific SOCS3 gene knockout mice.The genotypes of the offspring were identified by PCR,and the knockout effect was verified by Western blotting.The proportion of eMDSCs in the bone marrow of myeloid-specific SOCS3 gene knockout mice and their inhibitory effection T cells were detected by flow cytometry.Based on the myeloid-specific SOCS3 gene knockout mice,three kinds of tumor-bearing mouse model s include breast cancer,lung cancer,and melanoma with high infiltration of eMDSCs were constructed,and the infiltration of eMDSCs in tumors was detected by flow cytometry.Results:PCR results and Western blotting analysis confirmed that myeloid-specific SOCS3 gene knockout mice were successfully constructed.Flow cytometry results demonstrated that the proportion of eMDSCs in the bone marrow of myeloid-specific SOCS3 gene knockout mice was significantly increased(t=17.94,P<0.001),and the eMDSCs significantly inhibited T cell proliferation(t=14.21,P<0.001)and promoted T cell apoptosis(t=13.53,P<0.001).The number of eMDSCs was significantly increased in tumor tissue of three types of myeloid-specific SOCS3 gene knockout tumor-bearing mice with melanoma,breast cancer,and lung cancer(t=24.14,24.56,14.93,all P<0.001).Conclusion:Mouse models of cancer with high infiltration of eMDSCs are successfully constructed by specifically knocking out the SOCS3 gene of mouse myeloid cells.
作者 纪辰燕 李星晨 陈桂冬 于津浦 JI Chen-yan;LI Xing-chen;CHEN Gui-dong;YU Jin-pu(Cancer Molecular Diagnostics Core,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center of Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin′s Clinical Research Center for Cancer,Key Laboratory of Cancer Immunology and Biotherapy,Tianjin 300060,China)
出处 《天津医科大学学报》 2022年第3期253-259,共7页 Journal of Tianjin Medical University
基金 国家自然科学基金面上项目(81872143)。
关键词 Cre-loxP系统 SOCS3基因 组织特异性 小鼠 eMDSCs Cre-loxP system SOCS3 gene tissue specificity mouse eMDSCs
  • 相关文献

参考文献2

二级参考文献26

  • 1Pardoll D. Does the immune system see tumors as foreign or self? Annu Rev Imrnuno12003; 21:807-839.
  • 2Rabinovich CA, Gabrilovich D, Sotomayor EM. Immuno- suppressive strategies that are mediated by tumor cells. Annu Rev Immunol 2007; 25:267-296.
  • 3Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-174.
  • 4Kusmartsev S, Gabrilovich DI. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother 2006; 55:237-245.
  • 5Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007; 117:1155-1166.
  • 6Talmadge JE. Pathways mediating the expansion and im- munosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy. Clin Cancer Res 2007; 13:5243-5248.
  • 7Almand B, Clark JI, Nikitina E, van Beynen J, English NR, Knight SC, Carbone DP, Gabrilovich DI. Increased produc- tion of immature myeloid cells in cancer patients: a mecha- nism of immunosuppression in cancer. J Immunol 2001; 166: 678-689.
  • 8Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signo- retti S, Zabaleta J, McDermott D, Quiceno D, Youmans A, O'Neill A, Mier J, Ochoa AC. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mecha- nism of tumor evasion. Cancer Res 2005; 65:3044-3048.
  • 9Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-May- er E, Cole DJ, Montero AJ. Increased circulating myeloid- derived suppressor ceils correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophospha- mide chemotherapy. Cancer Immunol Immunother 2009; 58: 49-59.
  • 10Gallina G, Dolcetti L, Serafini P, De Santo C, Marigo I, Co- lombo MP, Basso G, Brombacher F, Borrello I, Zanovello P, Bicciato S, Bronte V. Tumors induce a subset of inflamma- tory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 2006; 116:2777-2790.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部